Pancreatic Cancer Research

ResearcherHuazhong University of Science and TechnologyNo recent work listed

Shan Yan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2875-5101; OpenAlex author ID A5053912853. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: 2 papers

Papers 3

  1. Structure-based analysis of a natural GOT1-inhibitor Aspulvinone H arrests pancreatic ductal adenocarcinoma cells growth First author DOI 10.22541/au.161881470.02929068/v1↗
  2. Discovery of GOT1 Inhibitors from a Marine-Derived Aspergillus terreus That Act against Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/md19110588↗
  3. Aspulvinone O, a natural inhibitor of GOT1 suppresses pancreatic ductal adenocarcinoma cells growth by interfering glutamine metabolism. Co-author DOI 10.1186/s12964-019-0425-4↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Weiguang Sun · 3 shared papers, 2019–2021 · strength 0.41
  2. Changxing Qi · 3 shared papers, 2019–2021 · strength 0.41
  3. Yonghui Zhang · 2 shared papers, 2021 · strength 0.31
  4. Qianqian Xu · 2 shared papers, 2021 · strength 0.31
  5. Yonghui Zhang · 1 shared paper, 2019 · strength 0.11
  6. Hua Li · 1 shared paper, 2019 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.